40·³ªºJ¤p©j¦b1¦~¥b«eº¦¸µo²{¯Ý³¡©MI³¡¦³¤Ö³\¤£³W«hªº¬õ´Ä¦â¤Î©@°Ø¦â´³¶ô¡AÁöµM¥¼·P¨ì¯kµh©Î
·kÄo¡A¦ý³o¨Ç¥Ö½§¯f¨_ÀHµÛ®É¶¡³vº¥¼W¥[¡A½¯©µ¦Ü¥|ªÏ¡C¦b¦h¤èÁÓÂà´NÂå«á¡A¦¿¤p©j¦Ü·s¦Ë»O¤j¤À°|¥ÍÂåÂå°|¥Ö½§³¡ªù¶E¨D¶E¡A¸gÀˬd¶EÂ_¬°¥Ö½§¨t²Î©Ê¼ß²ÓM¼W¥Í¯g¡]Cutaneous and systemic plasmacytosis¡A²ºÙCSP¡^¡C
CSP¦nµo©ó¨È¬w¤H ¥Ø«e¯Ê¥F³Ì¨ÎªvÀø¤è¦¡
·s¦Ë»O¤j¤À°|¥Ö½§³¡½²©û¾§Âå®v¸ÑÄÀ¡ACSP¬O¤@ºØ¥Dn¥H¥Ö½§¯gª¬ªí²{¡A¥B·¥¬°¨u¨£ªº¨t²Î©Ê¯e¯f¡A¦h¨£©ó¨È¬w¤H¡A¤×¨ä¬O¤é¥»¤Hªº³ø§iµS¦h¡C¦¹¯fªº¯f¦]¥Ø«e¤´¥¼½T»{¡A¦ý¥i¯à»PIL-6¡]¥Õ²ÓM¤¶¯À¡^µ¥²ÓM¦]¤lªº²§±`¼W°ª¦³Ãö¡CªvÀø¤è±¡A¾¨ºÞ¦³¦hºØªvÀø¿ï¾Ü¡A¥]§t¥~¥Î¡þ
¤fªAÃþ©T¾J¡B¥~¥Îcalcineurin§í¨î¾¯¡BÀR¯ß¤º§K¬Ì²y³J¥Õª`®g¡Brituximab¡Bthalidomide¡A¥H¤Îµµ¥~½u·Ó¥úªvÀøµ¥¡A¦ý¥Ø«e¯Ê¥F¤½»{³Ì¦³®Äªºº¿ïÀøªk¡C
Âå®v«Øij¯f¤H¡«á¤£§Ñ©w´Á°lÂÜ
½²©û¾§Âå®v»¡©ú¡AÁöµM¹³J¤p©j³oÃþ¶È¦³¥Ö½§ªí²{ªºÓ®×¡A³q±`¹w«á¨}¦n¡A¦ý¥Ñ©óCSP°¸º¸·|ªí²{¥X¸û¬°«Iŧ©Ê¤Î¦h¾¹©x«I¥ÇªºÁ{§É¶iµ{¡A«Øij¯f¤H¤´¶·©w´Áªº°lÂÜÀˬd¡A½T«O¤Î®Éµo²{¡BªvÀø¡A¤~¯à¦P¨B³B²z¥i¯àªº¬ÛÃö¨Öµo¯g¡C
½²©û¾§Âå®v´£¿ô¡AYµo²{¦³¥ô¦ó
¥Ö½§¯e¯f©Î¥Ö½§¤£©ú¯f¨_¡A³£À³ºÉ¦¿Ô¸ß¥Ö½§±M¬ìÂå®v¡A´£¨Ñ±M·~ªº¶EÂ_©MªvÀø¡A¤Á¤Å¬Û«H°¾¤è¡A¯Ô»~ªvÀøªºÄ_¶Q®É¶¡¡C¡]¯Î¹t¯§¡þ·s¦Ë³ø¾É¡^
¡]®Ö½Z½s¿è¡G³¯¦pÀ[¡^
¡]º¹Ï¨Ó·½¡þ¥x¤jÂå°|·s¦Ë¤À°|´£¨Ñ¡^
¨Ó·½¡G¥Ö½§¦³¤j¶q¬õ´³¥B¤£Â_½¯©µ¡H ³oºØ¯f¨È¬w¤H³Ì»Ýn¤p¤ß
¥X³B¡GNOW°·±d